[1] Makary MA,Daniel M.Medical error-the third leading cause of death in the US [J/OL].BMJ, 2016, 353:i2139. [2] Sevilla-Sanchez D, Molist-Brunet N, Amblàs-Novellas J,et al.Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission[J]. Eur J Clin Pharmacol, 2017, 73(1): 79-89. [3] WHO. The third WHO global patient safety challenge: medication without harm[EB/OL]. (2017-03-29)[2020-09-29].http://www.who.int/patientsafety/medication-safety/en/. [4] Institute for Healthcare Improvement.IHI global trigger tool for measuring adverse events[EB/OL].[2020-09-29]. http://www.ihi.org/resources/Pages/Tools/IHIGlobalTriggerToolforMeasuringAEs. aspx. [5] Varallo FR, Dagli-Hernandez C, Pagotto C, et al.Confounding variables and the performance of triggers in detecting unreported adverse drug reactions[J]. Clin Ther, 2017, 39(4): 686-696. [6] Zimlichman E, Gueta l, Daliyot D, et al. Adverse Drug Event Rate in Israeli Hospitals: Validation of an International Trigger Tool and an International Comparison Study[J]. Isr Med Assoc J, 2018, 20(11): 665-669. [7] Pandya AD, Patel K, Rana D,et al.Global trigger tool: proficient adverse drug reaction autodetection method in critical care patient units[J]. Indian J Crit Care Med, 2020, 24(3): 172-178. [8] Grossmann N, Gratwohl F, Musy SN, et al.Describing adverse events in medical inpatients using the Global Trigger Tool[J/OL].Swiss Med Wkly, 2019, 149: w20149. [9] Zottl M, Huf W, Ettl B, et al. Detection of adverse events using IHI Global Trigger Tool during the adoption of a risk management system: A retrospective study over three years at a department for cardiovascular surgery in Vienna[J].Z Evid Fortbild Qual Gesundhwes, 2018, 131-132: 38-45. [10] Karch FE, Lasagna L.Toward the operational identification of adverse drug reactions[J]. Clin Pharmacol Ther, 1997, 21(3): 247-254. [11] Liu Y, Jing Q, Bian Yuan, et al.Self-established clinical efficacy evaluation of 33 adverse drug event triggers in children[J].Adverse Drug Reactions Journal(药物不良反应杂志), 2019, 21(4): 273-280. [12] Guerra G, Srinivas TR, Meier-Kriesche HU.Calcineurin inhibitor-free immunosuppression in kidney transplantation[J]. Transpl Int, 2007, 20(10): 813-27. [13] David JT, Justin RS, Victoria MT, et al.Clinical and Economic Outcomes Associated with Medication Errors in Kidney Transplantation[J]. Clin J Am Soc Nephrol, 2014, 9(5): 960-966. [14] Padmanabhan G, Kamal K, Sandeep A.Active surveillance for adverse events among patients who underwent renal transplantation: A prospective observational study[J]. Perspect Clin Res, 2017, 8(3): 118-123. [15] Soha N, Mohammad MS, Iman K.Adverse Reactions of Immunosuppressive Drugs in Iranian Adult Kidney Transplant Recipients[J]. Exp Clin Transplant, 2012, 10(3): 224-31. [16] Michelle AA, James F, Deep BS, et al.Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients[J]. Surgery, 2018, 163(2): 430-435. [17] Lyece Y, Houria C, Hamama B, et al.Metabolic status of 1088 patients after renal transplantation: assessment of twelve years monitoring in algiers mustapha hospital[J]. Saudi J Kidney Dis Transpl, 2014, 25(1): 177-184. [18] Huang SL, Yu LX, Deng WF, et al.Long-term clinical follow-up of 2332 cases of long-term use of CsA after renal transplantation[J].Guangdong Med(广东医学), 2016, 37(6): 904-908. |